Michiaki Okuda

Design and synthesis of curcumin derivatives as tau and amyloid β dual aggregation inhibitors

Michiaki Okuda, Ichiro Hijikuro, Yuki Fujita et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 76 citations · Full text

Medicinal Chemistry, Natural Sciences, Medicine +6

PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8

Michiaki Okuda, Yuki Fujita, Ichiro Hijikuro et al. · Journal of Alzheimer s Disease · 2017 · 53 citations

PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo

Michiaki Okuda, Ichiro Hijikuro, Yuki Fujita et al. · PLoS ONE · 2015 · 33 citations · Full text

Motor Dysfunction, Sarkosyl-insoluble Aggregated Tau, Molecular Biology +20

Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation

Michiaki Okuda, Yuki Fujita, Yuki Takada‐Takatori et al. · PLoS ONE · 2020 · 30 citations · Full text

Geriatric Psychiatry, Aging, Neurochemical Biomarkers +21

Curcumin Derivative GT863 Inhibits Amyloid-Beta Production via Inhibition of Protein N-Glycosylation

Yasuomi Urano, Mina Takahachi, Ryo Higashiura et al. · Cells · 2020 · 26 citations · Full text